CACarmela Asteria

Carmela Asteria

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carmela Asteria has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Influence of yoga on the epigenetics of obesity: a study on its short- and medium-term benefits in the treatment of patients with severe/morbid obesity eligible for bariatric surgery

    by Carmela Asteria, Giorgia Scichilone, Rosanna Cardani, Dejan Lazarevic, Valentina Milani, Federico Ambrogi, Laura Valentina Renna, Marco Morelli, Francesca Giannese, Anna Sofia Tascini, et al.

    Background: Obesity is a growing global health problem characterised by chronic low-grade inflammation and epigenetic dysregulation. Epigenetic mechanisms—potentially reversible changes in gene expression occurring without alteration of the DNA sequence, most notably DNA methylation—are increasingly implicated in obesity-related inflammation. Yoga may act as complementary therapy. Objective: To explore whether participation in a structured yoga program is associated with changes in DNA methylation of TNF-α, and with clinical, hormonal, metabolic and psychological parameters, in patients with severe obesity awaiting bariatric surgery. Methods: In this prospective, non-randomised, controlled observational cohort study, 40 patients were analysed (20 yoga, 20 control). The intervention group underwent 36 PRANA_it yoga sessions over the 3 months preceding surgery (mean attendance 26/36, 72.5%). DNA methylation was profiled using a targeted three-gene inflammatory panel (TNF-α, IL-6, CRP). Between-group differences were estimated by baseline-adjusted ANCOVA. Results: Plasma noradrenaline was significantly lower in the yoga group at T1 after adjustment for baseline [adjusted difference −206.92, 95% CI (−349.62, −64.21), p = 0.0057]. SF-36 physical functioning differed between groups in the unadjusted change-score comparison ( p = 0.0206) but not after baseline adjustment [−8.69, 95% CI (−21.74, 4.36), p = 0.185]. Circulating TNF-α protein changed significantly more in the yoga group in the unadjusted analysis ( p = 0.0452), a finding with high variance. Vitamin D3 showed no significant adjusted difference at T1 ( p = 0.879); the T2 difference was borderline ( p = 0.064). DNA methylation of TNF-α, IL-6 and CRP showed no significant changes after correction for multiple comparisons. Psychological outcomes, a secondary domain, did not differ significantly between groups. Conclusion: In patients with severe obesity preparing for bariatric surgery, a structured preoperative yoga program was associated with a significant baseline-adjusted reduction in plasma noradrenaline, consistent with reduced sympathetic activation during a demanding phase of care. No epigenetic changes were detected, suggesting that measurable methylation remodelling may require longer exposure, larger samples, or tissue-specific sampling. These exploratory findings support yoga as a feasible, low-risk adjunct within bariatric prehabilitation, while the non-randomised design precludes causal inference. Adequately powered randomised trials with extended follow-up are needed to confirm this neuroendocrine signal.

  • Assessing Semi-Liquid Diets and Taste Alterations in Bariatric Surgery Patients: A Pilot Comparative Study of Foods for Special Medical Purpose and Traditional Weaning

    by Carmela Asteria, Michela Ravelli, Stefano Catania, Mariateresa Capuano, Alessandro Giovanelli

    Objective: Obesity is a global epidemic, associated with metabolic disorders and significant health risks. It is often treated with bariatric and metabolic surgery (BMS), such as Roux-en-Y gastric bypass and sleeve gastrectomy. These interventions impact not only weight loss but also taste perception and food preferences, possibly influencing dietary habits. This study investigates taste and nutritional outcomes during the post-BMS weaning phase, evaluating an alternative semiliquid diet with “Foods for Special Medical Purposes” (FSMPs) for improved taste acceptance and nutrient intake. Methods: Thirty-two patients undergoing BMS were divided into two groups 16 were placed on an FSMP-based diet (Group A) and 16 on traditional homogenized foods (Group B). Sensory evaluation included taste strips, sensory questionnaires, and weekly dietary questionnaires. Hematochemical analyses and bioimpedance measurements were conducted presurgery (T0) and 1-month postsurgery (T1) to assess nutrient status and body composition. Results: Patients in Group A showed improved protein intake and a trend toward better compliance with the FSMP diet. Significant changes in taste perception were noted, particularly for sour and salty tastes, with patients reporting altered taste intensity and preferences, especially for high-calorie foods. There were no significant differences in anthropometric or hematochemical outcomes between the groups, although FSMPs showed a marginal benefit in maintaining protein levels. Conclusions: FSMPs may offer an effective alternative in the post-BMS weaning phase, supporting nutrient intake and adherence to dietary guidelines. The observed changes in taste perception highlight the importance of tailored dietary strategies to support long-term dietary adjustment and weight management.

  • Open Access

    Epigenetic regulation role of SUV420H in sexual dimorphism of adipose tissue and obesity

    by Carmela Asteria, Roberta Caccia, Alessandro Giovanelli, Arianna Segaloni, Giorgia Scichilone, Alexis Elias Malavazos, Lelio Morricone, Danilo Parolini, Davide Gabellini, Simona Pedrotti

    Obesity is a worldwide health crisis linked to numerous harmful medical conditions. It arises from complex interactions between behavioral, environmental, and genetic factors. Interestingly, there is evidence of sexual dimorphism in the function of mitochondrial activity and metabolic flexibility of adipose tissue in obesity. Peroxisome proliferator-activated receptor-gamma (PPAR-γ), a critical factor in the formation of fat cells, glucose processing, and fat production, plays an essential role in the onset of obesity. Recently, it has been implicated in sex-based differences in adipose tissue gene expression and fat distribution. Epigenetic modifications mediate the effects of environmental factors by controlling the activity of genes related to metabolism. SUV420H1 and SUV420H2, histone methyltransferases that catalyze the addition of di- and trimethyl groups to lysine 20 of histone H4, suppress gene expression. Previous research has shown that SUV420H proteins respond to environmental signals by directly repressing PPAR-γ activity. In this study, we demonstrated that SUV420H1 and SUV420H2 are expressed differently between sexes in both human and mouse models. Interestingly, mice with a double knockout of Suv420h1 and Suv420h2 exhibit a sex-specific difference in their resistance to diet-induced obesity. Gene expression analysis of adipose tissue samples from obese humans reveals a significant inverse relationship between SUV420H and PPAR-γ expression in females, while no such correlation is observed in males. These findings highlight a potentially novel role for SUV420H proteins in modulating PPAR-γ activity, metabolic function, and the risk of obesity, with a clear sexual dimorphism in their effects.


  • Open Access

    Open-bore MRI Scanner Assessment of Epicardial Adipose Tissue after Bariatric Surgery: A Pilot Study

    by Carmela Asteria, Francesco Secchi, Lelio Morricone, Alexis Elias Malavazos, Simona Francesconi, Valentina Milani, Alessandro Giovanelli

    Background: The recognition of epicardial adipose tissue (EAT) as a cardiac risk factor has increased the interest in strategies that target cardiac adipose tissue. Aim: The effect of bariatric and metabolic surgery (BMS)-induced weight loss on EAT volume was evaluated in this study. Methods: Fifteen bariatric patients, with (MS) or without (wMS) Metabolic Syndrome, underwent magnetic resonance imaging (MRI) using an open-bore scanner to assess EAT volume, visceral adipose tissue (VAT) thickness, and other cardiac morpho-functional parameters at baseline and 12 months after BMS. Nine patients underwent laparoscopic sleeve gastrectomy (LSG), and 6 patients underwent Roux-en-Y Gastric Bypass (RYGBP). Results: EAT volume significantly decreased in all the patients 12 months post-BMS from 91.6 cm3 to 67.1 cm3; p = 0.0002 in diastole and from 89.4 cm3 to 68.2 cm3; p = 0.0002 in systole. No significant difference was found between the LSG and RYGBP group. Moreover, EAT volume was significantly reduced among wMS compared with MS. In particular, EAT volume in diastole was significantly reduced from 80.9 cm3 to 54.4 cm3; p = 0.0156 in wMS and from 98.3 cm3 to 79.5 cm3; p = 0.031 in MS. The reduction was also confirmed in systole from 81.2 cm3 to 54.1 cm3; p = 0.0156 in wMS and from 105.7 cm3 to 75.1 cm3; p = 0.031 in MS. Finally, a positive correlation was found between EAT loss, BMI (r = 0.52; p = 0.0443) and VAT (r = 0.66; p = 0.008) reduction after BMS. Conclusion: These findings suggest that EAT reduction may be a fundamental element for improving the cardio-metabolic prognosis of bariatric patients. Moreover, this is the first study performed with an open-bore MRI scanner to measure EAT volume.


  • Open Access

    Editorial: Endocrine disruptors in obesity

    by Carmela Asteria, Paola Silvia Morpurgo, Nadia Cerutti, Julianne M. Hall

    Endocrine disruptors or endocrine disrupting chemicals (EDCs) are natural or man-made chemicals that can be found in various environmental pollutants and everyday products, such as pesticides, heavy metals, food packaging or pharmaceuticals. EDCs can manifest deleterious effects by interfering with multiple aspects of the endocrine system, including augmentation or antagonism of endogenous hormone action. Many EDCs are recognized as “environmental obesogens”, capable of interfering with normal endocrine regulation of metabolism, adipose tissue development and maintenance, appetite, weight, and energy balance. An expanding body of scientific evidence from animal and epidemiological studies has begun to provide links between exposure to EDCs and obesity, In addition to EDCs and dysregulated hormone signaling, this editorial also highlights new insights into the role of inflammation in obesity.At the cellular level, obesogens can disrupt the endocrine system by altering the activity of peroxisome proliferator-activated receptors (PPARs) and steroid receptors, which are nuclear transcriptional regulators involved in lipid regulation and adipocyte differentiation. This interference can lead to changes in pro-adipogenic gene expression that ultimately contributes to adipogenesis. Genistein (GN) is a well-known bioflavonoid found in many food and plant sources. Xiang et al. highlighted how this phytoestrogen interferes with the endocrine system, modifies cellular activities, and curbs homeostasis by influencing both estrogen receptors and PPARγ, the latter of which is a pivotal switch for lipogenesis. GN acts as an obesogenic factor, inducing adipogenesis in a dose-dependent fashion, leading to lipid accumulation and transformation of stem cells into adipocytes in vitro.In addition to endocrine disruptors of natural origin, phthalates (PAEs), which are mainly used as plasticizers in the manufacturing of plastic products, are established EDCs. Exposure to PAEs disrupts sex hormone levels, contributing to an increased risk of obesity. To explore the association between PAEs and obesity from the perspective of sex hormones, Zhang et al. used multiple machine learning algorithms. Notably, they found that exposure to PAEs leads to an increase in estradiol and sex hormone binding globulin (SHBG) levels, while decreasing total testosterone (TT) levels. Estradiol was positively correlated with obesity, whereas TT and SHBG exhibited negative associations. These sex hormone imbalances related to PAEs exposure may account for the propensity to obesity. Viral infection and subsequent inflammatory reactions may be associated with obesity. Chen et al. found that brain regions are involved in the co-occurrence of Covid-19 and obesity. These regions help to maintain energy balance and homeostasis by perceiving and processing various metabolic signals in the hypothalamus. The excessive intake of saturated fatty acids can activate the innate immune system and impair adaptive immunity, leading to chronic inflammation and compromised host defense against viruses. These outcomes may be worsened by continued excessive fat intake. Moreover, COVID-19 patients with pituitary dysfunction experience changes in multiple endocrine organs, tissues, and hormone substances, making them susceptible to diabetes, obesity, and fractures. The authors suggested a close relationship between the management of pituitary diseases in the context of COVID-19 and the occurrence and development of complications.Evidence in this issue further suggests that the cytokines released in an inflammatory state may act as obesogens. Reyes-Farias et al. suggested a potential role of IL-16 in adipogenesis, lipid and glucose homeostasis, fibrosis, and inflammation in an obesity context. Obesity is associated with low-grade inflammation mainly due to immune cell infiltration of white adipose tissue (WAT). Proinflammatory cytokines including interleukin (IL)-16 are secreted by both adipocytes and infiltrated immune cells to upregulate inflammation. IL-16 correlates with body weight, BMI, and waist circumference, and individuals with extra weight are reported to have higher IL-16 plasma levels compared with normal-weight individuals. The authors found that IL-16 could be involved in inflammation, lipid accumulation, and altered glucose signaling, contributing to the development of metabolic diseases.Adipocytes themselves can interfere in the context of obesity. The morphology of adipocytes responds rapidly and dynamically to nutrient fluctuations. However, the adaptive hypertrophy of normal adipocytes may lead to an excessive fibrosis by inducing chronic inflammation, persistent hypoxia, and increasing myofibroblast numbers. Adipocyte-induced fibrosis not only restricts the flexible expansion and contraction of adipose tissue but also initiates the development of various diseases through cellular autocrine and paracrine effects. Zhang et al. suggested that modulation of adipocytes might provide potential therapeutic avenues for reversing pathological fibrosis in adipose tissue, achieving the anti-obesity purpose. Many browning-inducing drugs, which induce the formation of brown-like, thermogenic adipocytes in white fat depots, have been shown to have potent anti-fibrotic effects at the same time. However, at present, most of them have a wide range of targets, so the side effects should not be underestimated. Interestingly, also alterations in the expression or activity of specific small ubiquitin-like modifier (SUMO) system components can regulate the fate of adipocytes and the function of adipose tissue. SUMOylation is a post-translational modification which plays a crucial role in the pathogenesis of metabolic disorders such as obesity, insulin resistance, and fatty liver. Xie et al. (doi:10.3389/fendo.2024.1434338) highlighted how alterations in the expression or activity of specific SUMO system components may be associated with...


  • Low-Calorie Ketogenic Diet with Continuous Positive Airway Pressure to Alleviate Severe Obstructive Sleep Apnea Syndrome in Patients with Obesity Scheduled for Bariatric/Metabolic Surgery: a Pilot, Prospective, Randomized Multicenter Comparative Study

    by Luigi Schiavo, Roberto Pierro, Carmela Asteria, Pietro Calabrese, Alberto Di Biasio, Ilenia Coluzzi, Lucia Severino, Alessandro Giovanelli, Vincenzo Pilone, Gianfranco Silecchia

    Obstructive sleep apnea syndrome (OSAS) and obesity are frequently associated with hypertension (HTN), dyslipidemia (DLP), and insulin resistance (IR). In patients with obesity and OSAS scheduled for bariatric surgery (BS), guidelines recommend at least 4 weeks of preoperative continuous positive airway pressure (CPAP). Low-calorie ketogenic diets (LCKDs) promote pre-BS weight loss (WL) and improve HTN, DLP, and IR. However, it is unclear whether pre-BS LCKD with CPAP improves OSAS more than CPAP alone. We assessed the clinical advantage of pre-BS CPAP and LCKD in patients with obesity and OSAS. Seventy patients with obesity and OSAS were randomly assigned to CPAP or CPAP+LCKD groups for 4 weeks. The effect of each intervention on the apnea–hypopnea index (AHI) was the primary endpoint. WL, C-reactive protein (CRP) levels, HTN, DLP, and IR were secondary endpoints. AHI scores improved significantly in both groups (CPAP, p=0.0231; CPAP+LCKD, p=0.0272). However, combining CPAP and LCKD registered no advantage on the AHI score (p=0.863). Furthermore, body weight, CRP levels, and systolic/diastolic blood pressure were significantly reduced in the CPAP+LCKD group after 4 weeks (p=0.0052, p=0.0161, p=0.0008, and p=0.0007 vs baseline, respectively), and CPAP+LCKD had a greater impact on CRP levels than CPAP alone (p=0.0329). The CPAP+LCKD group also registered a significant reduction in serum cholesterol, LDL, and triglyceride levels (p=0.0183, p=0.0198, and p<0.001, respectively). Combined with CPAP, LCKD-induced WL seems to not have a significant incremental effect on AHI, HTN, DLP, and IR but lower CRP levels demonstrated a positive impact on chronic inflammatory status.


  • Open Access

    Italian Survey on Perception of Obesity and Bariatric and Metabolic surgery: a comparison between general practitioners and obese patients

    by Daniele Tassinari, Cecilia Lucia Andrea Giassi, Alessandro Giovanelli, Emanuela De Santis, Sara Boveri, Carmela Asteria

    Purpose Obesity is a pandemic, chronic and relapsing disease with several treatment options. The aim of this work was to investigate the level of awareness that people with obesity (PwO) have of their own condition and the level of knowledge regarding possible treatments available. To compare and contrast collected data on PwO with data obtained from general practitioners (GPs). Methods Data for this cross-sectional, non-interventional, descriptive study was collected via an online survey (CAWI methodology). 521 people were interviewed: 320 PwO and 201 GPs. Survey data were summarised in percentages and a 95% Confidence Interval (CI 95%). Results There is a lack of awareness of obesity as a disease among PwO. Firstly, most PwO (60%, 95% CI: 54%-65%) consider obesity to be an aesthetic problem and secondly a health problem (59%, 95% CI: 54%-65%). Conversely, 80% (95% CI: 74%-85%) of GPs consider obesity as a disease. The survey focus on the knowledge of bariatric and metabolic surgery (BMS) as a possible treatment option showed that only 12% of PwO (95% CI: 8%-16%) declared they had never heard about it, while 88% (95% CI: 84%-91%) declared they knew about it. Similarly, 95% (95% CI: 91%-98%) of GPs claim to know about BMS, but they recommended it only to 5% (95% CI:2%-9%) of their patients. In treating obesity GPs considered BMS less efficient than diet and physical activity (83% (95% CI: 77%-88%) vs 90% (95% CI: 84%-93%)) and to be indicated mainly for patients with comorbidities which cannot be controlled otherwise. Conclusions Our results indicate that implementing awareness campaigns for patients and GPs is currently as essential as providing structured programmes for obesity treatment. Moreover, it is still necessary to sensitize GPs on BMS which should be considered a standard obesity treatment option in selected cases. Level of evidence: Level V, cross-sectional, descriptive study.

  • Obesity: Medical and Surgical Treatment

    by Daniele Tassinari, Alessandro Giovanelli, Carmela Asteria


  • Top Cited Papers

    US-Elastography in the Differential Diagnosis of Benign and Malignant Thyroid Nodules

    by Carmela Asteria, Alessandra Giovanardi, Alessandro Pizzocaro, Luca Cozzaglio, Alberto Morabito, Francesco Somalvico, Adele Zoppo

    Background: Ultrasound (US)–elastography is a newly developed imaging technique for the reconstruction of tissue stiffness by measuring the degree of tissue's deformation in response to the application of an external force. This technique has previously been shown to be useful in the differential diagnosis between benign and malignant tumors. Methods: The objective of this study was to assess the diagnostic accuracy of US-elastography in the differential diagnosis of thyroid cancer, using the cytologic/histopathologic analysis as the reference standard. A total of 67 consecutive patients with thyroid nodules who were referred to the Thyroid Unit at the Policlinico MultiMedica were enrolled in this prospective study between January and December 2006. Eighty-six nodules in these patients were examined by US B-mode, US color-power-Doppler, and US-elastography. Nodules were subjected to fine-needle aspiration biopsy and patients with a reading of malignant or indeterminate had thyroid surgery. The final diagnosis was based on the cytology reading in those who did not have surgery and the histopathology reading in those who had surgery. US-elastography scores were based on four classes of tissue stiffness (class 1 for soft nodules; class 2 and 3 for nodules with an intermediate degree of stiffness; class 4 for anelastic lesions). Results: Seventeen nodules were malignant and 69 were benign. Sensitivity and specificity of the US-elastography for thyroid cancer diagnosis were 94.1% (16/17) and 81% (56/69), respectively. The positive and negative predictive values were 55.2% (16/29) and 98.2% (56/57), respectively. The accuracy of the technique was 83.7%. Conclusion: US-elastography is a promising technique that, combined with other US modalities, is easy and rapid to perform and can help to identify thyroid nodules that are likely to be malignant. An important limitation is probably lack of sensitivity for follicular thyroid carcinoma.